MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MTVA is expected to report earnings to rise 944.44% to -93 cents per share on November 05
Q3'26
Est.
$-0.94
Q2'26
Beat
by $0.73
Q1'26
Missed
by $0.45
Q4'25
Missed
by $0.52
Q3'25
Beat
by $0.18
The last earnings report on August 07 showed earnings per share of -9 cents, beating the estimate of -81 cents. With 20.90K shares outstanding, the current market capitalization sits at 8.83M.